Navigation Links
MannKind Corporation Reports Third Quarter Financial Results
Date:11/5/2008

nt credit

exchange - 831

Prepaid expenses and other current assets 7,709 9,596

Total current assets 102,942 378,712

Property and equipment - net 225,515 162,683

State research and development credit exchange

receivable - net of current portion 2,625 1,500

Other assets 550 548

Total $331,632 $543,443

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:

Accounts payable $19,992 $35,463

Accrued expenses and other current liabilities 36,087 32,095

Total current liabilities 56,079 67,558

Senior convertible notes 112,128 111,761

Other liabilities - 24

Total liabilities 168,207 179,343

Commitments and contingencies

Stockholders' equity:

Undesignated preferred stock, $0.01 par

value - 10,000,000 shares authorized; no shares

issued or outstanding at September 30, 2008 and

December 31, 2007 - -

Common stock, $0.01 par value - 150,000,000 shares

authorized; 101,710,590 and 101,380,823 shares

issued and outstanding at September 30, 2008 and

December 31, 2007, respectively 1,017 1,014

Additional paid-in capital 1,463,191 1,444,125

Deficit accumulated during the development

stage (1,300,783) (1,081,039)

Total stockholders' equity 163,42
'/>"/>

SOURCE MannKind Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. MannKind Corporation to Host Webcast Analyst Day September 16, 2008
2. The Leukemia & Lymphoma Society and MannKind Corporation Announce Collaborative Research Agreement
3. MannKind to Present at the Cowen and Company Healthcare Conference
4. MannKind Corporation Reports Fourth Quarter and Full Year 2007 Financial Results
5. MannKind Corporation Reports Third Quarter Financial Results
6. MannKind to Present at Upcoming Conferences
7. MannKind Announces New $350 Million Credit Facility
8. Providence Service Corporation Releases Third Quarter Results
9. United American Healthcare Corporation Announces Fiscal 2009 First Quarter Results
10. Psychemedics Corporation Announces Third Quarter Results
11. Somanetics Corporation to Present at Rodman & Renshaw Annual Global Investment Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... , WASHINGTON, Nov. 20 /PRNewswire-USNew... Bishops urged the Senate to make essential change... federal law on abortion funding and conscience pr...e for immigrants and include strong provisions for...the Senate health care bill an "enormous disappoin...
(Date:11/20/2009)... , MADISON, N.J., Nov. 20 /PRNewswire-Firs...uenza virus may have peaked in late October, but t...source of illness in all age groups, including the...ostics Incorporated (NYSE: DGX ), the world,s le...and services. ,, In its most recent Quest Diag...
(Date:11/20/2009)... , HAIFA, Israel, November 20 /PRNewsw...orp. (CVSL.OB), http://www.CVSLMEDICAL.COM , a le... technology, today announced that,the company,s Bo...plications,in Europe, Canada and the Far East for ...re" applicable for all angioplasty (PCTA) procedur...
(Date:11/20/2009)... , NEW YORK, Nov. 20 /PRNewswire-FirstCa...nounced that it will broadcast Doctor Radio Rep...ams , an in-depth special hosted by veteran journa...m.com/cgi-bin/prnh/20080819/NYTU044LOGO ) ,, D...now About Mammograms will air November 21 live ...
(Date:11/20/2009)...pot blood pressure readings in children with chron...n even during doctor,s office visits increasing ...ng to research from Johns Hopkins Children,s Cente... appears online in the Journal of American Society...ressure measurements obtained during regular docto...
Breaking Medicine News(10 mins):Health News:U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3Health News:Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 3Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 4Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 5Health News:High blood pressure easy to miss in children with kidney disease 2
...d IRVINE, Calif., May 18 /PRNewswire-FirstCall/ ...502) and IDM Pharma, Inc. (Nasdaq: IDMI ) today ...olly-owned subsidiary of Takeda (Takeda America), ...a wholly-owned subsidiary to effect that transacti...
...lth supplements product, helps slow and repair som...ens as we age , , MIAMI, May 18 RevGenetics anno...-based telomere health supplements , Astral... represent biomarkers of human aging and disease."...
...y-coding genes directly into muscles , , S... of an AIDS vaccine that might actually work, rese...gainst infection with simian immunodeficiency viru... Typically, vaccines are aimed at ramping up the i...
... research suggests that patients newly diagnosed w...course of the sleep aid, eszopiclone, when beginni...apy, are more adherent with therapy in six months....leads to multiple adverse effects on health and qu...
... Veronica De La Cruz is turning to the power of s...t to overcome healthcare red tape and save the lif... a heart transplant. , La...has turned into a major grassroots campaign throug...
... High-Tech Yet Simple Device "Rewires" ...ng , Haifa, Israel (PRWEB...ty" has a whole new meaning for people with ...e, represents a significant advance for Cerebral P...
Other Medicine News:Health News:Takeda to Acquire IDM Pharma, Adding MEPACT(R) (Mifamurtide), the First Treatment Approved for Osteosarcoma in More Than 20 Years, to Its Oncology Franchise 2Health News:Takeda to Acquire IDM Pharma, Adding MEPACT(R) (Mifamurtide), the First Treatment Approved for Osteosarcoma in More Than 20 Years, to Its Oncology Franchise 3Health News:Takeda to Acquire IDM Pharma, Adding MEPACT(R) (Mifamurtide), the First Treatment Approved for Osteosarcoma in More Than 20 Years, to Its Oncology Franchise 4Health News:Takeda to Acquire IDM Pharma, Adding MEPACT(R) (Mifamurtide), the First Treatment Approved for Osteosarcoma in More Than 20 Years, to Its Oncology Franchise 5Health News:Takeda to Acquire IDM Pharma, Adding MEPACT(R) (Mifamurtide), the First Treatment Approved for Osteosarcoma in More Than 20 Years, to Its Oncology Franchise 6Health News:RevGenetics Releases Its New Science-Based Telomere Health Supplement Formulation for DNA and Chromosome Health 2Health News:RevGenetics Releases Its New Science-Based Telomere Health Supplement Formulation for DNA and Chromosome Health 3Health News:RevGenetics Releases Its New Science-Based Telomere Health Supplement Formulation for DNA and Chromosome Health 4Health News:Vaccine Shields Monkeys From Simian Form of HIV 2Health News:Vaccine Shields Monkeys From Simian Form of HIV 3Health News:2-week course of sleep aid increases CPAP adherence in OSA patients at 6 months 2Health News:Twitter Boosts CNN Reporter's Fight to Save Her Brother's Life 2Health News:Twitter Boosts CNN Reporter's Fight to Save Her Brother's Life 3Health News:New Hope for Walking Normally, Living Better With Cerebral Palsy 2
(Date:11/20/2009)...K, Nov. 20 ,, Reportlinker.com ...ilable in its catalogue. ,, Global Markets for...portlinker.com/p0164741/Global-Markets-for-Breast-...;utm_medium=pr&utm_campaign=prnewswire ,,...udes the spring loaded core needle market and vacu...
(Date:11/20/2009)...ss. and LONDON, Nov. 20 ... announced that it has received 510(k) clearance f...d CE Mark approval to market its WallFlex® Fu...malignant esophageal strictures (obstructions) cau...esectable esophageal cancer. ,, (Photo: http...
(Date:11/20/2009)...MEETING, Pa., Nov. 20 I...at questions why currently available medications d...g ignored, ECRI Institute, an independent nonprofi...nce on Finasteride for Prevention of Prostate Can...009, New York Times article, " Drugs to Deter So...
Breaking Medicine Technology:Reportlinker Adds Global Markets for Breast Biopsy Devices 2009 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 2ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 3Blue Cross Blue Shield of Massachusetts and Atrius Health Sign Alternative Quality Contract 52114 1Blue Cross Blue Shield of Massachusetts and Atrius Health Sign Alternative Quality Contract 52114 2Blue Cross Blue Shield of Massachusetts and Atrius Health Sign Alternative Quality Contract 52114 3Blue Cross Blue Shield of Massachusetts and Atrius Health Sign Alternative Quality Contract 52114 4New e p t 28R 29 BabyCenter 28R 29 Fertility Report Reveals 70 Percent of Moms Want Tighter Regulation on In Vitro Fertilization 52112 1New e p t 28R 29 BabyCenter 28R 29 Fertility Report Reveals 70 Percent of Moms Want Tighter Regulation on In Vitro Fertilization 52112 2New e p t 28R 29 BabyCenter 28R 29 Fertility Report Reveals 70 Percent of Moms Want Tighter Regulation on In Vitro Fertilization 52112 3New e p t 28R 29 BabyCenter 28R 29 Fertility Report Reveals 70 Percent of Moms Want Tighter Regulation on In Vitro Fertilization 52112 4Labopharm receives complete response letter from the U S FDA for novel antidepressant 52110 1Labopharm receives complete response letter from the U S FDA for novel antidepressant 52110 2Labopharm receives complete response letter from the U S FDA for novel antidepressant 52110 3
... drug safety measure in 45 years; focus moves to,H...ire/ -- The Senate,today overwhelmingly passed sig...the Food and Drug Administration more power to dea...issue of drug,safety to the House, where a strong ...red. , "The Senate should be congratulated for pas...
...April 25, 2007-The U.S. Food and Drug,Administrati...f,Permanent Injunction against PharmaFab Inc., its...ark Tengler, PharmaFab,s president,and Russ McMah...o,stop the illegal manufacture and distribution of...The products are illegal because,they are not prod...
Other Medicine Technology:Senate Passes Drug-Safety Reforms to Prevent Future Vioxx-type,Disasters; House Urged to Act on Strong Drug Safety Bill 2Senate Passes Drug-Safety Reforms to Prevent Future Vioxx-type,Disasters; House Urged to Act on Strong Drug Safety Bill 3Senate Passes Drug-Safety Reforms to Prevent Future Vioxx-type,Disasters; House Urged to Act on Strong Drug Safety Bill 4Major Manufacturer of Unapproved and Adulterated Drugs 2Major Manufacturer of Unapproved and Adulterated Drugs 3
RIDASCREEN Anti-RSV IgA Assay
SAS RSV Test Kit
ImmunoCard STAT!® RSV
ImmunoCard STAT!® RSV PLUS
Medicine Products: